Core Viewpoint - NEXGEL and Vanalay have initiated a human trial to evaluate the effectiveness of NEXGEL's hydrogel in reducing harmful plume during laser hair removal procedures, with results expected in Q4 2024 [2][7]. Company Overview - NEXGEL is a leading provider of medical and over-the-counter (OTC) products, specializing in high-water-content hydrogels for healthcare and consumer applications, with a history of over two decades in developing electron-beam, cross-linked hydrogels [9]. - Innovative Optics, operating as Vanalay, is a prominent supplier of safety products and personal protective equipment for medical, surgical, and aesthetic healthcare facilities globally, established in 1993 [11]. Industry Context - Several states in the U.S. are implementing or considering mandates for surgical plume protection to mitigate health risks associated with airborne particles released during laser procedures [3]. - The application of NEXGEL's hydrogel may provide a solution for capturing plume during laser hair removal, potentially enhancing treatment effectiveness and reducing pain for patients [8]. Study Details - The study involves 30 patients and aims to measure the efficacy of NEXGEL's hydrogel in eliminating harmful particles during laser hair removal treatments [7]. - The trial is funded by Vanalay and conducted in compliance with FDA regulations, highlighting the collaboration between NEXGEL and Vanalay [7]. Executive Commentary - Adam Levy, CEO of NEXGEL, emphasized the broad range of applications for their hydrogel and the significance of the partnership with Vanalay in addressing health concerns for clinicians and patients during laser procedures [4].
NEXGEL and Innovative Optics US Initiate Institutional Review Board (IRB) Study in Accordance with FDA of Hydrogel Application During Laser Hair Removal